SkyOak Wealth’s Halozyme HALO Stock Holding History

SkyOak Wealth’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,898	Closed	-$556K	–	241
2021 Q1	$556K	Buy	+10,898	New	+$498K	0.15%	125

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SkyOak Wealth's HALO Position: Q2 2021 in Review

SkyOak Wealth sold out of Halozyme (HALO) in Q2 2021, closing a stake of 10,898 shares — an estimated $556K sold.

SkyOak Wealth first reported a position in HALO in Q1 2021 and held it in 1 quarter. The position peaked at $556K in Q1 2021. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

SkyOak Wealth reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
SkyOak Wealth sold 10,898 Halozyme shares in Q2 2021, an estimated $556K.
SkyOak Wealth first reported a position in Halozyme in Q1 2021 and held it in 1 quarter.
SkyOak Wealth's Halozyme position peaked at $556K in Q1 2021.
313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on SkyOak Wealth's 13F filing for Q2 2021, filed 19 Jul 2021.